Specialty chemicals manufacturer Camlin Fine Sciences Ltd. announced its Q3 FY25 financial results, reporting a revenue increase but a wider net loss compared to the previous year.
Revenue Growth
The company reported ₹435.5 crore in revenue from operations, reflecting an 8.7% year-on-year (YoY) growth from ₹385.8 crore in Q3 FY24. This growth was driven by steady demand for its antioxidant and specialty chemical products across key international markets. However, raw material price fluctuations and foreign exchange losses continued to weigh on overall profitability.
Net Loss
Despite revenue growth, Camlin posted a net loss of ₹158.2 crore, a sharp increase from ₹23.09 crore in Q3 FY24. The company attributed this to several factors, including impairments on overseas subsidiaries, non-cash adjustments, and foreign exchange losses. Additionally, total comprehensive loss for the quarter stood at ₹176.3 crore, reflecting the broader impact of these financial challenges.
Key Financial Metrics
- Revenue from operations: ₹435.5 crore (▲8.7% YoY)
- Net loss: ₹158.2 crore (▲587% YoY)
- Total expenses: ₹433.3 crore, driven by higher raw material costs and finance costs
- Earnings per share (EPS): -₹5.89, compared to -₹0.24 in Q2 FY25
Despite short-term challenges, Camlin remains focused on long-term growth through operational efficiencies and global expansion. The company has been making strategic acquisitions and investments in R&D and manufacturing capabilities to enhance its product portfolio. Management has also indicated efforts to improve cost controls and mitigate forex-related losses in upcoming quarters.
In addition to financial results, the Board of Directors approved key resolutions, including:
- Appointment of Mr. Abeezar Faizullabhoy as an Independent Director through a postal ballot.
- Modification of the Employee Stock Option Scheme (ESOP) 2021, aimed at aligning employee incentives with company performance.
While Camlin Fine Sciences faces short-term financial pressures, its long-term growth strategy remains intact. Investors will be keenly watching the company’s execution of cost-saving measures and expansion plans in the upcoming quarters.
For detailed financial disclosures, investors can refer to the company’s official website and stock exchange filings.
